Data-Driven Strategies for Carbimazole Titration: Exploring Machine Learning Solutions in Hyperthyroidism Control.
Authors: Reich, T., Bakirov, R., Budka, D., Kelly, D., Smith, J., Richardson, T. and Budka, M.
Journal: J Clin Endocrinol Metab
Volume: 110
Issue: 4
Pages: 1105-1114
eISSN: 1945-7197
DOI: 10.1210/clinem/dgae642
Abstract:BACKGROUND: University Hospitals Dorset (UHD) has more than 1000 thyroid patient contacts annually. These are primarily patients with autoimmune hyperthyroidism treated with carbimazole titration. Dose adjustments are made by a healthcare professional (HCP) based on the results of thyroid function tests, who then prescribes a dose and communicates this to the patient via letter. This is time consuming and introduces treatment delays. This study aimed to replace some time-intensive manual dose adjustments with a machine learning model to determine carbimazole dosing. This can in the future serve patients with rapid and safe dose determination and ease the pressures on HCPs. METHODS: Data from 421 hyperthyroidism patients at UHD were extracted and anonymized. A total of 353 patients (83.85%) were included in the study. Different machine learning classification algorithms were tested under several data processing regimes. Using an iterative approach, consisting of an initial model selection followed by a feature selection method, the performance was improved. Models were evaluated using weighted F1 scores and Brier scores to select the best model with the highest confidence. RESULTS: The best performance is achieved using a random forest (RF) approach, resulting in good average F1 scores of 0.731. A model was selected based on a balanced assessment considering the accuracy of the prediction (F1 = 0.751) and the confidence of the model (Brier score = 0.38). CONCLUSION: To simulate a use-case, the accumulation of the prediction error over time was assessed. It was determined that an improvement in accuracy is expected if this model was to be deployed in practice.
Source: PubMed
